Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Rheumatoid Arthritis

Free Subscription Articles published in J Rheumatol Retrieve available abstracts of 162 articles: HTML format

Single Articles

April 2024
1. RAMSAY D, Taylor T
   Does Changing Anticyclic Citrullinated Protein Testing From Restricted Ordering to Open Ordering Affect Healthcare Utilization and the Rate of Positive Testing?
   J Rheumatol. 2024;51:432-433.
   PubMed    
   
   
   
2. EVIATAR T, Furer V, Polachek A, Zisman D, et al
   Effect of Secukinumab and Tumor Necrosis Factor Inhibitors on Humoral Response to BNT162b2 mRNA Vaccine in Patients With Spondyloarthritis Compared to Immunocompetent Controls.
   J Rheumatol. 2024;51:415-422.
   PubMed     Abstract available
   
   
   March 2024
3. SUBDAR S, Hoens AM, White K, Hartfeld NMS, et al
   An environmental scan and appraisal of patient online resources for managing rheumatoid arthritis flares.
   J Rheumatol. 2024 Mar 15:jrheum.2023-1025. doi: 10.3899/jrheum.2023-1025.
   PubMed     Abstract available
   
   
   
4. WIENS D, Smolik IA, MacKay D, Fowler-Woods A, et al
   Perceived Access to Health Care of Indigenous Peoples in Canada with Rheumatoid Arthritis and their First-Degree Relatives.
   J Rheumatol. 2024 Mar 1:jrheum.2023-1080. doi: 10.3899/jrheum.2023-1080.
   PubMed     Abstract available
   
   
   
5. FONG KTD, Sng WJ, Lee KMV, Tan HSA, et al
   A Familiar Face in an Unfamiliar Place: Intraosseous Rheumatoid Nodule.
   J Rheumatol. 2024;51:314-315.
   PubMed    
   
   
   February 2024
6. PAPPAS DA, O'Brien J, Moore PC, Dodge R, et al
   Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results from the CorEvitas Rheumatoid Arthritis Registry.
   J Rheumatol. 2024 Feb 15:jrheum.2023-0752. doi: 10.3899/jrheum.2023-0752.
   PubMed     Abstract available
   
   
   
7. WIERCZEIKO A, Linke M, Friedrich JP, Koch J, et al
   A Call for Gene Expression Analysis in Whole Blood of Patients With Rheumatoid Arthritis (RA) as a Biomarker for RA-Associated Interstitial Lung Disease.
   J Rheumatol. 2024;51:130-133.
   PubMed     Abstract available
   
   
   
8. KRISTENSEN S, Hagelskjaer AM, Cordtz R, Bliddal S, et al
   Polyautoimmunity in patients with anti-cyclic citrullinated peptide antibody-positive and -negative rheumatoid arthritis: a nationwide cohort study from Denmark.
   J Rheumatol. 2024 Feb 1:jrheum.2023-0907. doi: 10.3899/jrheum.2023-0907.
   PubMed     Abstract available
   
   
   
9. GONZALEZ-GAY MA, Castaneda S, Ferraz-Amaro I
   Metabolic Syndrome: A Predisposing Factor for Rheumatoid Arthritis.
   J Rheumatol. 2024 Feb 1:jrheum.2023-1210. doi: 10.3899/jrheum.2023-1210.
   PubMed     Abstract available
   
   
   
10. HEMGREN C, Martinsson K, Rooney C, Wettero J, et al
    Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody-Positive At-Risk Individuals Without Arthritis.
    J Rheumatol. 2024;51:134-138.
    PubMed     Abstract available
    
    
    
11. FARRER C, Thib S, Eder L, Jerome D, et al
    Use of Coordinator Role Improves Access to Rheumatologic Advanced Therapy.
    J Rheumatol. 2024;51:197-202.
    PubMed     Abstract available
    
    
    January 2024
12. O'NEIL LJ, Alpizar-Rodriguez D, Deane KD
    Rheumatoid arthritis: The continuum of disease and strategies for prediction, early intervention and prevention.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0334. doi: 10.3899/jrheum.2023-0334.
    PubMed     Abstract available
    
    
    
13. STAMP LK, Keating P, Frampton C, Barclay ML, et al
    Relationship between adalimumab concentrations, anti-drug antibodies and disease activity in rheumatoid arthritis: a cross-sectional observational study.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0706. doi: 10.3899/jrheum.2023-0706.
    PubMed     Abstract available
    
    
    
14. LUO P, Xu W, Ye D, Chen W, et al
    Metabolic Syndrome Is Associated With an Increased Risk of Rheumatoid Arthritis: A Prospective Cohort Study Including 369,065 Participants.
    J Rheumatol. 2024 Jan 15:jrheum.2023-0349. doi: 10.3899/jrheum.2023-0349.
    PubMed     Abstract available
    
    
    December 2023
15. ZHUO N, Wang G, Wu G
    The Incidence of Herpes Zoster Is Increased in the Population of Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Dec 1:jrheum.2023-0249. doi: 10.3899/jrheum.2023-0249.
    PubMed     Abstract available
    
    
    November 2023
16. POSIO C, Suardi I, Caporali R, Ingegnoli F, et al
    Owning Pets Reduces the Perception of Disease Activity in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Nov 15:jrheum.2023-0950. doi: 10.3899/jrheum.2023-0950.
    PubMed     Abstract available
    
    
    
17. NOWELL WB, Barnes EL, Venkatachalam S, Kappelman MD, et al
    Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network.
    J Rheumatol. 2023;50:1503-1508.
    PubMed     Abstract available
    
    
    
18. MURAYAMA A
    Industry-Sponsored Research Funding to Rheumatologists in the United States Between 2014 and 2022.
    J Rheumatol. 2023;50:1510-1513.
    PubMed    
    
    
    
19. INANC N, Jousse-Joulin S, Abacar K, Cimsit C, et al
    The novel OMERACT Ultrasound Scoring System for salivary glands changes in patients with Sjogren's syndrome is associated with MRI and salivary flow rates.
    J Rheumatol. 2023 Nov 1:jrheum.2023-0202. doi: 10.3899/jrheum.2023-0202.
    PubMed     Abstract available
    
    
    October 2023
20. KWON HC, Kang MI, Kim SM
    Cystatin C as a Predictor of Renal function and Methotrexate-associated toxicities in Patients with Rheumatoid arthritis.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0218. doi: 10.3899/jrheum.2023-0218.
    PubMed     Abstract available
    
    
    
21. LEE JJY, Bernatsky S, Kwong JC, Li Q, et al
    Safety and Health Care Utilization following COVID-19 Vaccination among Adults with Rheumatoid Arthritis - A population-based self-controlled case series analysis.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0355. doi: 10.3899/jrheum.2023-0355.
    PubMed     Abstract available
    
    
    
22. KWOK TSH, Kuriya B, Eder L, Aghanya V, et al
    Low Nirmatrelvir/Ritonavir Use Among Patients With Rheumatoid Arthritis: A Signal of Concern.
    J Rheumatol. 2023 Oct 1:jrheum.2023-0439. doi: 10.3899/jrheum.2023-0439.
    PubMed     Abstract available
    
    
    
23. CHANG YH, Buras MR, Davis JM 3rd, Crowson CS, et al
    Avoiding Blunders When Analyzing Correlated Data, Clustered Data, or Repeated Measures.
    J Rheumatol. 2023;50:1269-1272.
    PubMed     Abstract available
    
    
    
24. ISLAM ST, Descallar J, Martens D, Hassett G, et al
    Screening for Anxiety in Patients With Inflammatory Arthritis Using the Multidimensional Health Assessment Questionnaire.
    J Rheumatol. 2023;50:1273-1278.
    PubMed     Abstract available
    
    
    
25. SHRIDHARMURTHY D, Lapane KL, Nunes AP, Baek J, et al
    Postpartum Depression in Reproductive-Age Women With and Without Rheumatic Disease: A Population-Based Matched Cohort Study.
    J Rheumatol. 2023;50:1287-1295.
    PubMed     Abstract available
    
    
    September 2023
26. BARTON JL
    Unequal Treatment: Physical Therapy Utilization in Rheumatoid Arthritis.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0814. doi: 10.3899/jrheum.2023-0814.
    PubMed     Abstract available
    
    
    
27. VISMAN I, Atiqi S, Boers M, Twisk J, et al
    Changes in TNF inhibitor drug survival in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis over 15 years.
    J Rheumatol. 2023 Sep 15:jrheum.2023-0149. doi: 10.3899/jrheum.2023-0149.
    PubMed     Abstract available
    
    
    
28. BRYNJARSDOTTIR HB, Bjursten S, Levin M, Gjertsson I, et al
    Successful Management of Checkpoint Inhibitor-Induced Arthritis With Disease-Modifying Antirheumatic Drugs During Active Immune Checkpoint Inhibition Treatment.
    J Rheumatol. 2023;50:1195-1197.
    PubMed    
    
    
    
29. YAMAMOTO K, Rokutanda R
    Disseminated Mycobacterium haemophilum Infection Mimicking Rheumatoid Nodules.
    J Rheumatol. 2023;50:1193.
    PubMed    
    
    
    August 2023
30. HAZLEWOOD GS, Akhavan P, Pardo Pardo J, Agarwal A, et al
    Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1.
    J Rheumatol. 2023 Aug 1:jrheum.2023-0625. doi: 10.3899/jrheum.2023-0625.
    PubMed     Abstract available
    
    
    
31. KAMEI R, Yamashita H, Kaneko H
    Clinical Characteristics and Predictors of the Recurrence of Organizing Pneumonia Associated with Rheumatoid Arthritis.
    J Rheumatol. 2023 Aug 1:jrheum.2023-0037. doi: 10.3899/jrheum.2023-0037.
    PubMed     Abstract available
    
    
    
32. LANE CY, Lo D, Thoma LM, Zhang T, et al
    Sociocultural and Economic Disparities in Physical Therapy Utilization among Insured Older Adults with Rheumatoid Arthritis.
    J Rheumatol. 2023 Aug 1:jrheum.2023-0103. doi: 10.3899/jrheum.2023-0103.
    PubMed     Abstract available
    
    
    July 2023
33. CHARLES-SCHOEMAN C, Hyde C, Guan S, Parikh N, et al
    Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients with Rheumatoid Arthritis Receiving Tofacitinib.
    J Rheumatol. 2023 Jul 15:jrheum.2023-0112. doi: 10.3899/jrheum.2023-0112.
    PubMed     Abstract available
    
    
    
34. MOUSA J, Peterson MN, Crowson CS, Achenbach SJ, et al
    Validating the FRAX Score in a US Population-Based Study of Patients with Rheumatoid Arthritis.
    J Rheumatol. 2023 Jul 1:jrheum.2022-1293. doi: 10.3899/jrheum.2022-1293.
    PubMed     Abstract available
    
    
    
35. WANG G, Liu Z
    The Relationship Between Red Cell Distribution Width, Absolute Lymphocyte Count, and Rheumatoid Arthritis.
    J Rheumatol. 2023 Jul 1:jrheum.2023-0321. doi: 10.3899/jrheum.2023-0321.
    PubMed     Abstract available
    
    
    June 2023
36. CURRY PDK, Chinoy H, Jani M, Plant D, et al
    The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK Cohort.
    J Rheumatol. 2023 Jun 15:jrheum.2022-1277. doi: 10.3899/jrheum.2022-1277.
    PubMed     Abstract available
    
    
    
37. ALBAYRAK F, Koc E
    Rheumatoid Arthritis or Imitator?
    J Rheumatol. 2023 Jun 1:jrheum.2022-1253. doi: 10.3899/jrheum.2022-1253.
    PubMed     Abstract available
    
    
    
38. BESSETTE L, Rahman P, Kelsall J, Purvis J, et al
    Incidence and Determinants of Infection in Rheumatoid Arthritis Patients Treated with Golimumab in Real-World After a Median Follow-up Time of 27 Months.
    J Rheumatol. 2023 Jun 1:jrheum.2022-1283. doi: 10.3899/jrheum.2022-1283.
    PubMed     Abstract available
    
    
    
39. YAMAMOTO M, Fujita Y
    Bywaters Lesions: A Rare Cutaneous Vasculitis in Rheumatoid Arthritis.
    J Rheumatol. 2023 Jun 1:jrheum.2023-0169. doi: 10.3899/jrheum.2023-0169.
    PubMed     Abstract available
    
    
    
40. HAROON M, Javed S, Ullah S, Hashmi F, et al
    Prevalence of Stress at Home and Its Significant Associations Among Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Jun 1:jrheum.2023-0044. doi: 10.3899/jrheum.2023-0044.
    PubMed     Abstract available
    
    
    
41. LIAO Z, Tian F, Yao F, Wen Z, et al
    Rheumatoid Vasculitis-Associated Foot Gangrene.
    J Rheumatol. 2023;50:845.
    PubMed    
    
    
    May 2023
42. GREENE GJ, Beaumont JL, Bacalao EJ, Muftic A, et al
    Integrating PROMIS Measures in a Treat to Target (T2T) Approach to Standardize Patient-Centered Treatment of Rheumatoid Arthritis.
    J Rheumatol. 2023 May 1:jrheum.2022-1176. doi: 10.3899/jrheum.2022-1176.
    PubMed     Abstract available
    
    
    April 2023
43. CURTIS JR, Emery P, Kricorian G, Yen PK, et al
    Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2023 Apr 15:jrheum.2022-1008. doi: 10.3899/jrheum.2022-1008.
    PubMed     Abstract available
    
    
    
44. MCWILLIAMS DF, Walsh DA
    Inflammatory and Noninflammatory Disease Activity in Rheumatoid Arthritis: The Effect of Pain on Personalized Medicine.
    J Rheumatol. 2023 Apr 1:jrheum.230158. doi: 10.3899/jrheum.230158.
    PubMed     Abstract available
    
    
    
45. VAN ONNA M, Boonen A
    Frailty in Inflammatory Arthritis: A Fragile Construct.
    J Rheumatol. 2023;50:463-465.
    PubMed    
    
    
    
46. BARDAN I, Fagerli KM, Sexton J, Kvien TK, et al
    Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD.
    J Rheumatol. 2023;50:538-547.
    PubMed     Abstract available
    
    
    March 2023
47. MYASOEDOVA E, Kurmann RD, Achenbach SJ, Wright K, et al
    Trends in incidence of chronic heart failure (HF) in patients with rheumatoid arthritis: a population-based study validating different HF definitions.
    J Rheumatol. 2023 Mar 15:jrheum.221170. doi: 10.3899/jrheum.221170.
    PubMed     Abstract available
    
    
    February 2023
48. DAVTYAN A, Lee JJY, Eder L, Hawker GA, et al
    The Effects of Continuity of Rheumatology Care on Emergency Department Utilization and Hospitalizations for Individuals With Early Rheumatoid Arthritis: A Population-Based Study.
    J Rheumatol. 2023 Feb 1:jrheum.220996. doi: 10.3899/jrheum.220996.
    PubMed     Abstract available
    
    
    
49. KAUR J, Cairns E, Barra L
    Restoring Balance: Immune Tolerance in Rheumatoid Arthritis.
    J Rheumatol. 2023 Feb 1:jrheum.220881. doi: 10.3899/jrheum.220881.
    PubMed     Abstract available
    
    
    
50. SINGER D, Thompson-Leduc P, Poston S, Gupta D, et al
    Incidence of Herpes Zoster in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study.
    J Rheumatol. 2023 Feb 1:jrheum.220986. doi: 10.3899/jrheum.220986.
    PubMed     Abstract available
    
    
    
51. ITO Y, Nakahara H, Nakajima A
    Development of Pulmonary Alveolar Proteinosis in a Patient With Adult-Onset Still Disease Treated With Tocilizumab.
    J Rheumatol. 2023;50:288-289.
    PubMed    
    
    
    
52. WENG J, Zhou LL, Hahn T, Shojania K, et al
    Adult-Onset Still Disease After ChAdOx1 nCOV-19 Vaccination.
    J Rheumatol. 2023;50:290-291.
    PubMed    
    
    
    
53. MAICA GL, Iannaccone C, Feathers V, Frits ML, et al
    Understanding Differences in Patient Descriptions of Rheumatoid Arthritis Flares Using OMERACT Core Domains.
    J Rheumatol. 2023 Feb 1:jrheum.211409. doi: 10.3899/jrheum.211409.
    PubMed     Abstract available
    
    
    January 2023
54. WOHLFAHRT A, Muhammad LF, Song J, Dunlop D, et al
    Pain Mechanisms Associated with Disease Activity in Patients with Rheumatoid Arthritis Treated with DMARDs: A Regression Tree Analysis.
    J Rheumatol. 2023 Jan 15:jrheum.220500. doi: 10.3899/jrheum.220500.
    PubMed     Abstract available
    
    
    
55. BARBER CEH, Lacaille D, Croxford R, Barnabe C, et al
    Investigating Associations Between Access to Rheumatology Care, Treatment, Continuous Care, and Healthcare Utilization and Costs Among Older Individuals With Rheumatoid Arthritis.
    J Rheumatol. 2023 Jan 15:jrheum.220729. doi: 10.3899/jrheum.220729.
    PubMed     Abstract available
    
    
    
56. COOK C, Patel NJ, Fu X, Wang X, et al
    Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines against COVID-19 infection among patients with systemic autoimmune rheumatic diseases on immunomodulatory medications.
    J Rheumatol. 2023 Jan 15:jrheum.220870. doi: 10.3899/jrheum.220870.
    PubMed     Abstract available
    
    
    
57. VIGNOS PJ JR, Parker WT, Thompson HM
    Evaluation of a Clinic Education Program for Patients with Rheumatoid Arthritis.
    J Rheumatol. 2023;50:156-165.
    PubMed     Abstract available
    
    
    December 2022
58. GORZEWSKI AM, Heisler AC, Neogi T, Muhammad LN, et al
    Predicting Disease Activity in Rheumatoid Arthritis with the Fibromyalgia Survey Questionnaire: Does the Severity of Fibromyalgia Symptoms Matter?
    J Rheumatol. 2022 Dec 15:jrheum.220507. doi: 10.3899/jrheum.220507.
    PubMed     Abstract available
    
    
    November 2022
59. WANG G, Zhuo N, Wen Z
    Clinically Active Rheumatoid Arthritis and the Presence of Cardiovascular Disease Are Associated With an Elevated Risk of Dementia Incidence.
    J Rheumatol. 2022 Nov 15. pii: jrheum.220934. doi: 10.3899/jrheum.220934.
    PubMed     Abstract available
    
    
    
60. KLOSE-JENSEN R, Therkildsen J, Blavnsfeldt AG, Langdah B, et al
    The minimal erosive volume needed for radiographic identification of erosions in the metacarpophalangeal joints in patients with rheumatoid arthritis.
    J Rheumatol. 2022 Nov 15. pii: jrheum.220623. doi: 10.3899/jrheum.220623.
    PubMed     Abstract available
    
    
    
61. DUMOULIN QA, Verstappen M, van der Helm van Mil AHM, van Steenbergen HW, et al
    Joint Damage Over Time in Patients With Early Rheumatoid Arthritis Follows Trajectories Related to Distinct Courses of Disease Activity.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220531. doi: 10.3899/jrheum.220531.
    PubMed     Abstract available
    
    
    
62. LANGE A, Kostadinova L, Damjanovska S, Gad I, et al
    Red Cell Distribution Width and Absolute Lymphocyte Count Associate with Biomarkers of Inflammation and Subsequent Mortality in Rheumatoid Arthritis.
    J Rheumatol. 2022 Nov 1. pii: jrheum.211411. doi: 10.3899/jrheum.211411.
    PubMed     Abstract available
    
    
    
63. TAKANASHI S, Takeuchi T, Kaneko Y
    Impacts of ageing on rheumatoid factor and anti-cyclic citrullinated peptide antibody positivity in patients with rheumatoid arthritis.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220526. doi: 10.3899/jrheum.220526.
    PubMed     Abstract available
    
    
    
64. SATTUI SE, Lieber SB
    Keep It in Mind: Assessing the Risk of Dementia in Patients With Rheumatoid Arthritis and Opportunities for Intervention.
    J Rheumatol. 2022 Nov 1. pii: jrheum.220991. doi: 10.3899/jrheum.220991.
    PubMed     Abstract available
    
    
    
65. TAYLOR PC
    The Opportunities and Challenges of Telemedicine in the Management of People With Rheumatoid Arthritis.
    J Rheumatol. 2022;49:1188-1190.
    PubMed    
    
    
    October 2022
66. TCHETINA EV
    Baseline Gene Expression Analysis in the Peripheral Blood of Patients With Rheumatoid Arthritis as an Important Supplement to Standard Composite Measure.
    J Rheumatol. 2022 Oct 15. pii: jrheum.220795. doi: 10.3899/jrheum.220795.
    PubMed     Abstract available
    
    
    
67. ISNARDI CA, Cerda OL, Landi M, Cruces L, et al
    Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines.
    J Rheumatol. 2022 Oct 1. pii: jrheum.220469. doi: 10.3899/jrheum.220469.
    PubMed     Abstract available
    
    
    
68. GLINTBORG B, Jensen DV, Terslev L, Hendricks O, et al
    Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases.
    J Rheumatol. 2022;49:1163-1172.
    PubMed     Abstract available
    
    
    September 2022
69. DESSEIN PH, Stanwix AE, Solomon A
    How Could Physical Activity Reduce Inflammation and Inflammatory Gene Expression in Rheumatoid Arthritis?
    J Rheumatol. 2022 Sep 15. pii: jrheum.220788. doi: 10.3899/jrheum.220788.
    PubMed     Abstract available
    
    
    
70. VAN DIJK B, van der Helm-van Mil A
    Delayed Referral of Female Patients With Rheumatoid Arthritis: Where Are We Now? A Study Spanning 3 Decades.
    J Rheumatol. 2022 Sep 15. pii: jrheum.220429. doi: 10.3899/jrheum.220429.
    PubMed     Abstract available
    
    
    
71. FAYET F, Darmant N, Rodere M, Fan A, et al
    The Practice of Argentine Tango in Patients With Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Study, a Positive Experience.
    J Rheumatol. 2022 Sep 15. pii: jrheum.220103. doi: 10.3899/jrheum.220103.
    PubMed     Abstract available
    
    
    
72. PENABAD IC
    The Prism of Inequity: Health Disparities in Rheumatoid Arthritis.
    J Rheumatol. 2022;49:1070-1071.
    PubMed    
    
    
    
73. VENKATACHALAM S, Nowell WB
    Taking the Long View: Patients Perceive Benefits and Risks of Treatment as Multidimensional.
    J Rheumatol. 2022;49:971-973.
    PubMed    
    
    
    August 2022
74. FERRAZ-AMARO I, Sheikh A, Polack B, Giles JT, et al
    Articular (18)Fluorodeoxyglucose Uptake Is Associated with Clinically Assessed Swollen Joint Count in Patients with Rheumatoid Arthritis.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220231. doi: 10.3899/jrheum.220231.
    PubMed     Abstract available
    
    
    
75. MENG CF, Rajesh DA, Jannat-Khah DP, Jivanelli B, et al
    Can Patients with Controlled Rheumatoid Arthritis Taper Methotrexate from Targeted Therapy and Sustain Remission? A Systematic Review and Meta-analysis.
    J Rheumatol. 2022 Aug 15. pii: jrheum.220152. doi: 10.3899/jrheum.220152.
    PubMed     Abstract available
    
    
    
76. BAGGETT K, Brandon TG, Xiao R, Valenzuela Z, et al
    Incidence Rates of Psoriasis in Children With Inflammatory Bowel Disease and Juvenile Arthritis Treated With Tumor Necrosis Factor Inhibitors and Disease-Modifying Antirheumatic Drugs.
    J Rheumatol. 2022;49:935-941.
    PubMed     Abstract available
    
    
    July 2022
77. HAZLEWOOD GS, Pardo JP, Barnabe C, Schieir O, et al
    Canadian Rheumatology Association living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying anti-rheumatic drugs.
    J Rheumatol. 2022 Jul 15. pii: jrheum.220209. doi: 10.3899/jrheum.220209.
    PubMed     Abstract available
    
    
    
78. KODISHALA C, Hulshizer CA, Kronzer VL, Davis JM 3rd, et al
    Risk Factors for Dementia in Patients with Incident Rheumatoid Arthritis: A Population-based Cohort Study.
    J Rheumatol. 2022 Jul 15. pii: jrheum.220200. doi: 10.3899/jrheum.220200.
    PubMed     Abstract available
    
    
    
79. PATTERSON SL, Sun S, Rychkov D, Katz P, et al
    Physical Activity Associates with Lower Systemic Inflammatory Gene Expression in Rheumatoid Arthritis.
    J Rheumatol. 2022 Jul 1. pii: jrheum.220050. doi: 10.3899/jrheum.220050.
    PubMed     Abstract available
    
    
    June 2022
80. DAVIS JM 3RD
    The Patient Experience of Drug Side Effects in Rheumatoid Arthritis: Intriguing Data From an Exploratory Online Survey.
    J Rheumatol. 2022 Jun 15. pii: jrheum.220412. doi: 10.3899/jrheum.220412.
    PubMed     Abstract available
    
    
    
81. AVOUAC J, Molto A, Frantz C, Wanono S, et al
    Evaluation of patients with rheumatoid arthritis in teleconsultation during the first wave of the COVID-19 pandemic.
    J Rheumatol. 2022 Jun 15. pii: jrheum.220073. doi: 10.3899/jrheum.220073.
    PubMed     Abstract available
    
    
    
82. MOORE MN, Wallace BI, Song J, Muhammad LN, et al
    Correlation of fibromyalgia survey questionnaire and quantitative sensory testing among patients with active rheumatoid arthritis.
    J Rheumatol. 2022 Jun 1. pii: jrheum.220046. doi: 10.3899/jrheum.220046.
    PubMed     Abstract available
    
    
    
83. DARABIAN S, Wade JP, Kur J, Wade SD, et al
    Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience.
    J Rheumatol. 2022;49:558-565.
    PubMed     Abstract available
    
    
    
84. NASH P
    Janus Kinase Inhibitors: Safety in Patients With Psoriatic Arthritis.
    J Rheumatol. 2022;49.
    PubMed     Abstract available
    
    
    
85. BESSETTE L, Mysler E, Kinch CD, Kwok K, et al
    Impact of Tofacitinib on Components of the ACR Response Criteria: Post Hoc Analysis of Phase III and Phase IIIb/IV Trials.
    J Rheumatol. 2022;49:566-576.
    PubMed     Abstract available
    
    
    
86. LUBBERTS E, Scher JU, FitzGerald O
    Basic Science Session 2. Recent Advances in Our Understanding of Psoriatic Arthritis Pathogenesis.
    J Rheumatol. 2022;49.
    PubMed     Abstract available
    
    
    May 2022
87. CAGNOTTO G, Jacobsson THL, Rydell E, Eberhard A, et al
    Male Sex Predicts a Favorable Outcome in Early ACPA-negative Rheumatoid Arthritis: Data From An Observational Study.
    J Rheumatol. 2022 May 2. pii: jrheum.211199. doi: 10.3899/jrheum.211199.
    PubMed     Abstract available
    
    
    
88. DIRENZO DD, Robinson S, Bingham CO 3rd, Baer AN, et al
    PROMIS Provides a Broader Overview of Health-related Quality of Life Than the ESSPRI in Evaluation of Sjogren Syndrome.
    J Rheumatol. 2022;49:470-474.
    PubMed     Abstract available
    
    
    
89. EDER L, Croxford R, Drucker AM, Mendel A, et al
    COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
    J Rheumatol. 2022;49:523-530.
    PubMed     Abstract available
    
    
    
90. WIDDIFIELD J, Eder L, Chen S, Kwong JC, et al
    COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis.
    J Rheumatol. 2022;49:531-536.
    PubMed     Abstract available
    
    
    April 2022
91. LIAO PY, Liao SL, Liaw YP
    Extraarticular Manifestations and Comorbidities in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2022 Apr 15. pii: jrheum.211278. doi: 10.3899/jrheum.211278.
    PubMed     Abstract available
    
    
    
92. VERWEIJ NJF, de Jongh J, Ter Wee MM, Zwezerijnen GJC, et al
    Whole body macrophage PET imaging for disease activity assessment in early rheumatoid arthritis.
    J Rheumatol. 2022 Apr 15. pii: jrheum.210928. doi: 10.3899/jrheum.210928.
    PubMed     Abstract available
    
    
    
93. ZICKUHR L, Mandell BF
    Rheumatology Education Needs a Splash of Color.
    J Rheumatol. 2022;49:343-345.
    PubMed    
    
    
    March 2022
94. MCDERMOTT G, Gill R, Gagne S, Byrne S, et al
    Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211242. doi: 10.3899/jrheum.211242.
    PubMed     Abstract available
    
    
    
95. HADWEN B, Yu R, Cairns E, Barra L, et al
    Presence of Autoantibodies in Males and Females with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    J Rheumatol. 2022 Mar 15. pii: jrheum.211020. doi: 10.3899/jrheum.211020.
    PubMed     Abstract available
    
    
    
96. YAZDANYAR A, Donato A, Wasko MC, Ward MM, et al
    Risk of 30-day Readmission After Knee or Hip Replacement in Rheumatoid Arthritis and Osteoarthritis by Non-Medicare and Medicare Payer Status.
    J Rheumatol. 2022;49:340.
    PubMed    
    
    
    
97. HAZLEWOOD GS, Schieir O, Bykerk V, Mujaab K, et al
    Frequency of symptomatic adverse events in rheumatoid arthritis: an exploratory online survey.
    J Rheumatol. 2022 Mar 1. pii: jrheum.210688. doi: 10.3899/jrheum.210688.
    PubMed     Abstract available
    
    
    
98. KREMER JM, Reed G, Pappas DA, Kane K, et al
    Dr. Kremer et al reply.
    J Rheumatol. 2022;49:338-339.
    PubMed    
    
    
    February 2022
99. MOVAHEDI M, Cesta A, Li X, Keystone EC, et al
    Physician and Patient Reported Effectiveness are similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data from a Rheumatoid Arthritis Registry.
    J Rheumatol. 2022 Feb 15. pii: jrheum.211066. doi: 10.3899/jrheum.211066.
    PubMed     Abstract available
    
    
    
100. LE MOINE C, Soyfoo MS, Mekkaoui L, Dahma H, et al
     Impaired humoral immunogenicity of SARS-CoV-2 vaccination in rheumatoid arthritis patients.
     J Rheumatol. 2022 Feb 1. pii: jrheum.211270. doi: 10.3899/jrheum.211270.
     PubMed     Abstract available
     
     
     
101. DE ANGELIS R, Giuggioli D, Bajocchi G, Dagna L, et al
     Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology.
     J Rheumatol. 2022;49:176-185.
     PubMed     Abstract available
     
     
     
102. BERARDICURTI O, Pavlych V, Cola ID, Ruscitti P, et al
     Long-term Safety of Rituximab in Primary Sjogren Syndrome: The Experience of a Single Center.
     J Rheumatol. 2022;49:171-175.
     PubMed     Abstract available
     
     
     
103. KAWADA T
     Smoking, Obesity, and Risk of Primary Sjogren Syndrome.
     J Rheumatol. 2022;49:234.
     PubMed    
     
     
     
104. BERTI A, Cornec D, Crowson CS, Matteson EL, et al
     Dr. Berti et al reply.
     J Rheumatol. 2022;49:234.
     PubMed    
     
     
     
105. GRIFFITHS H, Smith T, Mack C, Leadbetter J, et al
     Persistence to Biologic Therapy Among Patients With Ankylosing Spondylitis: An Observational Study Using the OPAL Dataset.
     J Rheumatol. 2022;49:150-156.
     PubMed     Abstract available
     
     
     January 2022
106. PAZMINO S, Lovik A, Westhovens R, Verschueren P, et al
     Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication.
     J Rheumatol. 2022 Jan 15. pii: jrheum.210871. doi: 10.3899/jrheum.210871.
     PubMed     Abstract available
     
     
     
107. BREDEMEIER M, Ranza R, Kakehasi AM, Ranzolin A, et al
     Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
     J Rheumatol. 2022;49:122.
     PubMed    
     
     
     December 2021
108. KREMER JM, Pappas DA, Kane K, Greenberg J, et al
     The Clinical Disease Activity Index and the Routine Assessment of Patient Index Data 3 for Achievement of Treatment Strategies.
     J Rheumatol. 2021;48:1776-1783.
     PubMed     Abstract available
     
     
     November 2021
109. WIENS D, Smolik I, Meng X, Anaparti V, et al
     Functional disability to evaluate the risk of arthritis in First-degree relatives of Rheumatoid Arthritis patients.
     J Rheumatol. 2021 Nov 1. pii: jrheum.210614. doi: 10.3899/jrheum.210614.
     PubMed     Abstract available
     
     
     
110. AGUIRRE A, Yazdany J
     Hepatitis B Screening Before Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drug Therapy: Many Roads to Improvement.
     J Rheumatol. 2021 Nov 1. pii: jrheum.211000. doi: 10.3899/jrheum.211000.
     PubMed     Abstract available
     
     
     October 2021
111. PINCUS T, Bergman MJ, Yazici Y
     Should Quantitative Measures and Management of Rheumatoid Arthritis Include More Than Control of Inflammatory Activity?
     J Rheumatol. 2021 Oct 15. pii: jrheum.210953. doi: 10.3899/jrheum.210953.
     PubMed     Abstract available
     
     
     
112. KRONZER VL, Huang W, Zaccardelli A, Crowson CS, et al
     Association of sinusitis and upper respiratory tract diseases with incident rheumatoid arthritis: A case-control study.
     J Rheumatol. 2021 Oct 15. pii: jrheum.210580. doi: 10.3899/jrheum.210580.
     PubMed     Abstract available
     
     
     
113. STUDENIC P, Radner H
     Back to Basics: Prioritizing Communication as a Key Instrument in Managing Rheumatoid Arthritis.
     J Rheumatol. 2021 Oct 1. pii: jrheum.210984. doi: 10.3899/jrheum.210984.
     PubMed     Abstract available
     
     
     
114. YAZDANYAR A, Donato A, Wasko MC, Ward MM, et al
     Risk of 30-day Readmission after Knee or Hip Replacement in Rheumatoid Arthritis and Osteoarthritis by non-Medicare and Medicare Payer Status.
     J Rheumatol. 2021 Oct 1. pii: jrheum.201370. doi: 10.3899/jrheum.201370.
     PubMed     Abstract available
     
     
     
115. CHATZIDIONYSIOU K, Hetland ML, Frisell T, Di Giuseppe D, et al
     Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis.
     J Rheumatol. 2021;48:1512-1518.
     PubMed     Abstract available
     
     
     
116. SAFY-KHAN M, de Hair MJH, Welsing PMJ, van Laar JM, et al
     Current Smoking Negatively Affects the Response to Methotrexate in Rheumatoid Arthritis in a Dose-responsive Way, Independently of Concomitant Prednisone Use.
     J Rheumatol. 2021;48:1504-1507.
     PubMed     Abstract available
     
     
     September 2021
117. VAN DER HEIJDE D, Kartman CE, Xie L, Beattie S, et al
     Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with rheumatoid arthritis: Results from RA-BEYOND.
     J Rheumatol. 2021 Sep 15. pii: jrheum.210346. doi: 10.3899/jrheum.210346.
     PubMed     Abstract available
     
     
     
118. FERNANDES BM, Pereira JM, Pereira PR, Bernardes M, et al
     Tuberculosis Presenting as an Inflammatory Pseudotumor of the Sciatic Nerve in a Rheumatoid Arthritis Patient Taking Etanercept.
     J Rheumatol. 2021 Sep 15. pii: jrheum.210540. doi: 10.3899/jrheum.210540.
     PubMed     Abstract available
     
     
     
119. VAN WEELY SFE
     The Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis: A Closer Look at the Results of a Review.
     J Rheumatol. 2021 Sep 1. pii: jrheum.210822. doi: 10.3899/jrheum.210822.
     PubMed     Abstract available
     
     
     
120. BEKKER CL, Bossina S, de Vera MA, Bartlett SJ, et al
     Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group Study.
     J Rheumatol. 2021;48:1480-1487.
     PubMed     Abstract available
     
     
     August 2021
121. WANG X, Hefton A, Ni K, Ukadike KC, et al
     Autoantibodies against unmodified and citrullinated human endogenous retrovirus K envelope protein in rheumatoid arthritis patients.
     J Rheumatol. 2021 Aug 1. pii: jrheum.201492. doi: 10.3899/jrheum.201492.
     PubMed     Abstract available
     
     
     
122. MEER E, Thrastardottir T, Wang X, Dubreuil M, et al
     Risk factors for diagnosis of psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis: A set of parallel case-control studies.
     J Rheumatol. 2021 Aug 1. pii: jrheum.210006. doi: 10.3899/jrheum.210006.
     PubMed     Abstract available
     
     
     
123. HAZLEWOOD GS, Bombardier C, Li X, Movahedi M, et al
     Heterogeneity in patient characteristics and differences in treatment across four Canadian rheumatoid arthritis cohorts.
     J Rheumatol. 2021 Aug 1. pii: jrheum.201688. doi: 10.3899/jrheum.201688.
     PubMed     Abstract available
     
     
     
124. CHEN YW, Tsai PY, Wei JC
     Lymphoma and Sjogren Syndrome: A Common Overlapping Syndrome?
     J Rheumatol. 2021;48:1343.
     PubMed    
     
     
     
125. RIPSMAN DA, Bookman AAM
     Correlation Between Subjective and Objective Severity of Oral and Ocular Dryness in Primary Sjogren Syndrome.
     J Rheumatol. 2021;48:1290-1294.
     PubMed     Abstract available
     
     
     
126. BEAUMONT JL, Davis ES, Curtis JR, Cella D, et al
     Meaningful Change Thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue and Pain Interference Scores in Patients With Rheumatoid Arthritis.
     J Rheumatol. 2021;48:1239-1242.
     PubMed     Abstract available
     
     
     
127. VU M, Carvalho N, Clarke PM, Buchbinder R, et al
     Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis.
     J Rheumatol. 2021;48:1221-1229.
     PubMed     Abstract available
     
     
     
128. BOERS M, Pincus T
     Long-term Glucocorticoid Use in Rheumatoid Arthritis.
     J Rheumatol. 2021;48:1342.
     PubMed    
     
     
     July 2021
129. KAHLER J, Mastarone G, Matsumoto R, ZuZero D, et al
     It may help you to know. . .": The early phase qualitative development of a rheumatoid arthritis goal elicitation tool.
     J Rheumatol. 2021 Jul 1. pii: jrheum.201615. doi: 10.3899/jrheum.201615.
     PubMed     Abstract available
     
     
     
130. JARROT PA, Arcani R, Darmon O, Roudier J, et al
     Axial Articular Manifestations in Primary Sjogren Syndrome: Association With Spondyloarthritis.
     J Rheumatol. 2021;48:1037-1046.
     PubMed     Abstract available
     
     
     
131. ORNETTI P, Guillier D, Jeudy G
     Perforating Rheumatoid Nodule Mimicking Malignant Soft-tissue Mass of the Forearm.
     J Rheumatol. 2021;48:1103.
     PubMed    
     
     
     
132. YUN H, Xie F, Chen L, Yang S, et al
     Evaluation of the Effect of Diabetes on Rheumatoid Arthritis-related Outcomes in an Electronic Health Record-based Rheumatology Registry.
     J Rheumatol. 2021;48:992-1001.
     PubMed     Abstract available
     
     
     
133. MCCOY SS, Bartels CM, Saldanha IJ, Bunya VY, et al
     National Sjogren's Foundation Survey: Burden of Oral and Systemic Involvement on Quality of Life.
     J Rheumatol. 2021;48:1029-1036.
     PubMed     Abstract available
     
     
     
134. FOX RI, Fox CM
     Axial Articular Manifestations in Primary Sjogren Syndrome: Have We Been Missing Spondyloarthritis for All This Time?
     J Rheumatol. 2021;48:963-964.
     PubMed    
     
     
     
135. HANLY JG, Lethbridge L
     Use of Disease-modifying Antirheumatic Drugs, Biologics, and Corticosteroids in Older Patients With Rheumatoid Arthritis Over 20 Years.
     J Rheumatol. 2021;48:977-984.
     PubMed     Abstract available
     
     
     June 2021
136. BATHON JM
     Is the Gap in Incidence of Cardiovascular Events in Rheumatoid Arthritis Really Closing?
     J Rheumatol. 2021 Jun 15. pii: jrheum.210366. doi: 10.3899/jrheum.210366.
     PubMed     Abstract available
     
     
     
137. JANSEN G, de Rotte MCFJ, de Jonge R
     Smoking and Methotrexate Inefficacy in Rheumatoid Arthritis: What About Underlying Molecular Mechanisms?
     J Rheumatol. 2021 Jun 15. pii: jrheum.210217. doi: 10.3899/jrheum.210217.
     PubMed     Abstract available
     
     
     
138. GOULIELMOS GN, Zervou MI
     Risk of Venous Thromboembolism in Ankylosing Spondylitis and Rheumatoid Arthritis: Genetic Aspects.
     J Rheumatol. 2021 Jun 15. pii: jrheum.210131. doi: 10.3899/jrheum.210131.
     PubMed     Abstract available
     
     
     
139. FERREIRA RJO, Landewe RBM, da Silva JAP
     Definition of Treatment Targets in Rheumatoid Arthritis: Is It Time for Reappraisal?
     J Rheumatol. 2021 Jun 1. pii: jrheum.210050. doi: 10.3899/jrheum.210050.
     PubMed     Abstract available
     
     
     
140. SPARKS JA
     Multimorbidity Accrual After Incident Rheumatoid Arthritis: A Wolf at the Door.
     J Rheumatol. 2021 Jun 1. pii: jrheum.210224. doi: 10.3899/jrheum.210224.
     PubMed     Abstract available
     
     
     
141. MARKOUSIS-MAVROGENIS G, Mavrogeni SI
     Cutting the "Gordian Knot" - Cardiac Involvement in Primary Sjogren Syndrome.
     J Rheumatol. 2021;48:802-803.
     PubMed    
     
     
     
142. LINDBERG H, Colliander C, Nise L, Dahlqvist J, et al
     Are Farming and Animal Exposure Risk Factors for the Development of Granulomatosis With Polyangiitis? Environmental Risk Factors Revisited: A Case-control Study.
     J Rheumatol. 2021;48:894-897.
     PubMed     Abstract available
     
     
     
143. NISHIWAKI A, Kobayashi H, Ikumi N, Kobayashi Y, et al
     Salivary Gland Focus Score Is Associated With Myocardial Fibrosis in Primary Sjogren Syndrome Assessed by a Cardiac Magnetic Resonance Approach.
     J Rheumatol. 2021;48:859-866.
     PubMed     Abstract available
     
     
     May 2021
144. JACOBS JWG, Verhoeven MMA, Welsing PMJ
     Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests.
     J Rheumatol. 2021 May 15. pii: jrheum.201510. doi: 10.3899/jrheum.201510.
     PubMed     Abstract available
     
     
     
145. PIANAROSA E, Hazlewood G, Thomas M, Hsiao R, et al
     Supporting Equity in Rheumatoid Arthritis Outcomes in Canada: Population-Specific Factors in Patient-Centered Care.
     J Rheumatol. 2021 May 15. pii: jrheum.210016. doi: 10.3899/jrheum.210016.
     PubMed     Abstract available
     
     
     
146. RAMPES S, Patel V, Bosworth A, Jacklin C, et al
     Systematic review and meta-analysis of the reproducibility of patient self-reported joint counts in rheumatoid arthritis.
     J Rheumatol. 2021 May 15. pii: jrheum.201439. doi: 10.3899/jrheum.201439.
     PubMed     Abstract available
     
     
     
147. TANIGUCHI Y, Kimata T
     Yellow Nail Syndrome Associated With Rheumatoid Arthritis.
     J Rheumatol. 2021;48:785.
     PubMed    
     
     
     
148. BREDEMEIER M, Ranza R, Kakehasi AM, Ranzolin A, et al
     Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (Biobadabrasil).
     J Rheumatol. 2021 May 1. pii: jrheum.201248. doi: 10.3899/jrheum.201248.
     PubMed     Abstract available
     
     
     
149. JOHANSSON FD, Collins JE, Yau V, Guan H, et al
     Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine Learning.
     J Rheumatol. 2021 May 1. pii: jrheum.201626. doi: 10.3899/jrheum.201626.
     PubMed     Abstract available
     
     
     
150. LIU Y, Zhang S, Xia CS, Chen J, et al
     Elevated Granulocyte Colony-stimulating Factor Levels in Patients With Active Phase of Adult-onset Still Disease.
     J Rheumatol. 2021;48:664-668.
     PubMed     Abstract available
     
     
     April 2021
151. TANAKA Y, Takeuchi T, Soen S, Yamanaka H, et al
     Effects of denosumab in Japanese rheumatoid arthritis patients treated with conventional anti-rheumatic drugs: 36-month extension of a phase 3 study.
     J Rheumatol. 2021 Apr 15. pii: jrheum.201376. doi: 10.3899/jrheum.201376.
     PubMed     Abstract available
     
     
     
152. KARLSSON SUNDBAUM J, Arkema EV, Bruchfeld J, Jonsson J, et al
     Tuberculosis in biologic-naive patients with rheumatoid arthritis - risk factors and tuberculosis characteristics.
     J Rheumatol. 2021 Apr 1. pii: jrheum.201251. doi: 10.3899/jrheum.201251.
     PubMed     Abstract available
     
     
     
153. LIANG YT, Leong PY, Wei JC
     Questions on the Bidirectional Relationship Between Primary Sjogren Syndrome and Non-Hodgkin Lymphoma.
     J Rheumatol. 2021;48:620.
     PubMed    
     
     
     March 2021
154. DEVAUCHELLE-PENSEC V
     Ultrasonography of the Salivary Gland in Primary Sjogren Syndrome: Usefulness to Phenotype the Patients.
     J Rheumatol. 2021 Mar 1. pii: jrheum.201433. doi: 10.3899/jrheum.201433.
     PubMed     Abstract available
     
     
     January 2021
155. PANCHOVSKA M
     Questions From Patients and Doctors on Negative Minor Salivary Gland Biopsy in Sjogren Syndrome.
     J Rheumatol. 2021;48:149.
     PubMed    
     
     
     
156. MONSALVE DM, Anaya JM
     Drs. Monsalve and Anaya reply.
     J Rheumatol. 2021;48:149.
     PubMed    
     
     
     October 2020
157. MOSSEL E, van Nimwegen JF, Stel AJ, Wijnsma RF, et al
     Clinical phenotyping of primary Sjogren's patients using salivary gland ultrasonography - data from the RESULT cohort.
     J Rheumatol. 2020 Oct 1. pii: jrheum.200482. doi: 10.3899/jrheum.200482.
     PubMed     Abstract available
     
     
     August 2020
158. GROSSE J, Allado E, Albuisson E, Pierreisnard A, et al
     The USSe (UltraSound Score for Erosions) in the evaluation of bone erosions in RA compared to the SHSe (Van der Heijde-modified Sharp score for erosions).
     J Rheumatol. 2020 Aug 15. pii: jrheum.200286. doi: 10.3899/jrheum.200286.
     PubMed     Abstract available
     
     
     May 2020
159. SAHINKAYA Y, Mumcu G, Ozdemir FT, Kurus RE, et al
     Are Salivary Gland Ultrasonography Scores Associated with Salivary Flow Rates and Oral Health Related Quality of Life in Sjogren's syndrome?
     J Rheumatol. 2020 May 1. pii: jrheum.190849. doi: 10.3899/jrheum.190849.
     PubMed     Abstract available
     
     
     February 2020
160. WARD JM, Hess JN, Davis LS
     Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome.
     J Rheumatol. 2020;47:298-299.
     PubMed    
     
     
     September 2019
161. RUACHO G, Kvarnstrom M, Zickert A, Oke V, et al
     Sjogren's syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state.
     J Rheumatol. 2019 Sep 15. pii: jrheum.190250. doi: 10.3899/jrheum.190250.
     PubMed     Abstract available
     
     
     August 2019
162. RENNER N, Kleyer A, Kronke G, Simon D, et al
     T2 Mapping as a New Method for Quantitative Assessment of Cartilage Damage in RA.
     J Rheumatol. 2019 Aug 15. pii: jrheum.180728. doi: 10.3899/jrheum.180728.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.